Magnesium

Category
mineral
Half-Life (t½)
PO: 12h · IV: 12h
Daily Value (RDI)
420 mg (UL: 350 mg)
Formula
Mg
Molecular Weight
24.31 g/mol
PubChem CID
5462224
Aliases
Mg²⁺, Mg glycinate, Mg citrate, Mg malate, Mg threonate

Pharmacological Mechanism

Mg²⁺ stabilises ATP (Mg-ATP is the catalytically active form) and serves as a cofactor for 300+ enzymes including kinases, phosphatases, and glycolytic/TCA/oxidative phosphorylation steps. Voltage-dependent block of glutamate receptor pharmacology receptor Ca²⁺ channels drives the sleep-onset and neuroprotective effects. Required for DNA/RNA and protein synthesis. CNS penetration is form-dependent — threonate raises CSF Mg²⁺ measurably in rodent models (Slutsky 2010).

Dietary Reference Intake

FDA Daily Value 420 mg (21 CFR 101.9). NIH ODS UL 350 mg/d applies only to SUPPLEMENTAL magnesium; dietary intake above is generally safe.

Half-Life & Elimination Curve (PO: 12h · IV: 12h)

100%50%25%12.5%0%0h0×t½12h1×t½24h2×t½36h3×t½48h4×t½60h5×t½0×t½ (0h): 100% remaining (~0.105 mg/L)1×t½ (12h): 50% remaining (~52.7 µg/L)2×t½ (24h): 25% remaining (~26.4 µg/L)3×t½ (36h): 12.5% remaining (~13.2 µg/L)4×t½ (48h): 6.3% remaining (~6.59 µg/L)5×t½ (60h): 3.1% remaining (~3.3 µg/L)
Plasma (PO)t½ Decay (12h)
  • 0×t½0h100% (0.105 mg/L)
  • 1×t½12h50% (52.7 µg/L)
  • 2×t½24h25% (26.4 µg/L)
  • 3×t½36h12.5% (13.2 µg/L)
  • 4×t½48h6.3% (6.59 µg/L)
  • 5×t½60h3.1% (3.3 µg/L)
Elimination t½12h (PO)
Rate Constant (ke)0.0578 h⁻¹
Time to Peak (Tmax)4.88h
Est. Peak (Cmax)0.105 mg/L
Clearance (CL)60.7 L/h
97% Washout (5×t½)60h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Top Dietary Sources

Chemical Structure & Identifiers

References